代谢物调解肠道微生物群和NAFLD之间的因果关系:一个门德尔的随机化研究
Chen Ouyang1, Pengpeng Liu1, Yiwei Liu1
1Department of Hepatobiliary Surgery, Tianjin Medical University General Hospital, Tianjin, 300052, P.R. China.
BMC gastroenterology
|July 31, 2024
概括
肠道微生物Ruminococcus2的大量增加可能会降低非酒精性脂肪肝疾病 (NAFLD) 的风险. 这种效果似乎是由血代谢物,如氨酸-氨酸二硫化物和3-氨酸3-氨酸酸介导的.
科学领域:
- 微生物组研究的研究.
- 代谢学 代谢学 代谢学
- 遗传流行病学遗传流行病学
背景情况:
- 非酒精性脂肪性肝病 (NAFLD) 与改变的肠道微生物群和血清代谢物有关.
- 之前的观察性研究显示了不一致的结果,可能是由于混因素和反向因果关系.
研究的目的:
- 为了澄清肠道微生物群和血液代谢物对NAFLD的因果关系,使用孟德尔随机化 (MR).
主要方法:
- 两步MR分析使用来自MiBioGen和英国生物银行的全基因组关联研究 (GWAS) 数据.
- 使用的错误发现率 (FDR) 校正和链接不平衡回归 (LDSC) 分析.
- 进行了敏感性分析,包括cML-MA和双向MR,以确保结果的稳定性.
主要成果:
- 确定了9种肠道微生物群和7种与NAFLD显著相关的代谢物.
- 发现了Ruminococcus2丰富度和NAFLD风险之间的因果关系 (OR=0.74,P=0.0012).
- 鲁米诺菌2的丰富度与氨酸-氨酸二硫化物 (OR=1.17,P=0.041) 和3-氨酸酸 (OR=1.18,P=0.036) 水平的增加相关,分别介导了11.2%和7.5%的效果.
结论:
- 特定的肠道微生物群,如Ruminococcus2,可能会降低NAFLD风险.
- 这种保护作用可能是通过血液代谢物水平的变化来调节的.
相关概念视频
01:18Dysbiosis of the Gut Microbiota
The human gut microbiome includes a diverse array of microbial species, including beneficial commensals and opportunistic pathogens, which interact to support host health. These microbes contribute to essential functions such as nutrient metabolism, immune system modulation, and maintenance of intestinal barrier integrity. However, disruptions to this equilibrium—referred to as dysbiosis—can have widespread physiological consequences.Dysbiosis is often characterized by reduced microbial...
01:21Microbiota Modulation by Antibiotics
Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...